BPC-157 and TB-500 are WADA-banned and FDA-flagged for compounding
In some embodiments, the sustained release of the therapeutic agent is in the middle ear
However, up to 70% of patients with symptoms typical of GERD have normal endoscopic findings, with so-called nonerosive reflux disease, and additional tests are required to identify increased esophageal exposure to acid
External resources Development of new sublingual formulation for transmucosal delivery of peptides (PubMed) Systemic delivery of proteins using novel peptides via the sublingual route (ScienceDirect) Approaches for enhancing oral bioavailability of peptides and proteins (PMC) For researchers serious about optimizing their peptide protocols across every delivery method, SeekPeptides offers the most comprehensive resource available
The frequency of B-12 injections can vary based on individual needs and health conditions
Metformin, a diabetes drug, also lowers B12 absorption